Expanding Capabilities

Liquids & Semisolids

What Makes a Great Liquid Oral Dose CDMO?

Rob Terry

TriRx Pharmaceutical Services

High-Concentration

High-Concentration Biologics Are Redefining Subcutaneous Delivery

Pharma's Almanac

Pathfinder

Offshoring vs. Reshoring vs. Half-Shoring: Which Manufacturing Strategy Is Best for Pharma?

Pharma's Almanac

LAI Formulation

The Formulation Science Behind Extended Drug Release

Pharma's Almanac

Drug–Device

Designing Formulations Around Devices Rather Than Vice Versa

Pharma's Almanac

Tech Transfer

Why Successful Scale-Up and Transfer Capabilities Increasingly Determine Outsourcing Success

Pharma's Almanac

Organoids

Building Bioreactors for Living Architecture: The Manufacturing Challenge for Clinical-Grade Organoids

David Alvaro, Ph.D.

Pharma's Almanac

Cell-Free Synthesis

Cell-Free Biomanufacturing and the Future of Flexible Biologics Production

David Alvaro, Ph.D.

Pharma's Almanac

Peptides

Enabling the Commercialization of Peptide Therapeutics with Manufacturing Advances

Cynthia A. Challener, Ph.D.

Pharma's Almanac

AI in Manufacturing

Validating and Governing AI in GMP Manufacturing

Pharma's Almanac

AI Data Integrity

Data Integrity in the Age of AI-Assisted Manufacturing

Pharma's Almanac